Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men
Table 1
Demographic information of participants in different cognitive statuses (total sample size: ).
MMSE scores
Total
28 ≤ MMSE ≤ 30
24 ≤ MMSE ≤ 27
MMSE ≤ 23
Age, years,
76 ± 9.5, 316
83.9 ± 8.3, 93
89.1 ± 5.0, 31
440
<0.001
BMI,
24.6 (22.7–26.5), 316
24.0 (22.5–27.1), 93
22.7 (21.2–25.9), 31
440
0.096
AS levels, , %
0
23 (7.3%)
1 (1.1%)
0 (0%)
24 (5.5%)
<0.001
I
228 (72.2%)
60 (64.5%)
14 (45.2%)
302 (68.6%)
II
65 (20.6%)
32 (34.4%)
17 (54.8%)
114 (25.9%)
Hs-CRP (mg/L)
<0.3
99 (32.8%)
21 (25.3%)
10 (38.5%)
130 (31.6%)
0.128
0.3~1
149 (49.3%)
36 (43.4%)
9 (34.6%)
194 (47.2%)
1~3
43 (14.2%)
19 (22.9%)
6 (23.1%)
68 (16.5%)
≥3
11 (3.6%)
7 (8.4%)
1 (3.8%)
19 (4.6%)
Comorbidities, , %
1
2 (0.6%)
2 (2.2%)
0 (0%)
4 (0.9%)
0.13
2
5 (1.6%)
1 (1.1%)
0 (0%)
6 (1.4%)
3
17 (5.4%)
1 (1.1%)
2 (6.5%)
20 (4.5%)
4
30 (9.5%)
4 (4.3%)
2 (6.5%)
36 (8.2%)
5
43 (13.6%)
10 (10.8%)
3 (9.7%)
56 (12.7%)
6
62 (19.6%)
18 (19.4%)
8 (25.8%)
88 (20.0%)
7
61 (19.3%)
24 (25.8%)
8 (25.8%)
93 (21.1%)
8
60 (19.0%)
11 (11.8%)
7 (22.6%)
78 (17.7%)
9
29 (9.2%)
17 (18.3%)
1 (3.2%)
47 (10.7%)
10
7 (2.2%)
5 (5.4%)
0 (0%)
12 (2.7%)
One-way ANOVA was used to test the differences of age and BMI in different groups. Pearson Chi-Squared test was used for categorical variables. Fisher’s Exact Test was used for examining AS levels and comorbidities. In AS levels, compared to 24 ≤ MMSE ≤ 27, ; compared to MMSE ≤ 23, .
